I welcome the decision on the benefits that cystic fibrosis patients will enjoy as a result of the decision to make two drugs available. I thank the Minister for Health and the Department for coming to an agreement on that issue. We also need to look at the agreement between pharmaceutical companies and the Government over 12 months ago on a saving of over €600 million in the cost of drugs. We are paying approximately €2.6 billion in real terms for drugs and pharmaceuticals every year. My understanding is that there are a number of other drugs which have been presented to the body which decides on drug availability and in respect of which negotiations are ongoing. These drugs would benefit a large number of patients. I understand there has been quite a delay in making a decision on those drugs being brought into the system. I ask the Leader to raise the matter with the Minister so that these drugs might also be made available at an early date. While I welcome the decision on Orkambi and the other drug which is now available to cystic fibrosis patients, we have a great deal more work to do. However, this is also about trying to keep the cost of drugs down because a huge number of people can benefit if drugs are cheaper. That is an extremely important issue as well.